stefania pallotta

Dr. stefania pallotta

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in European Journal of Cancer
Verified
Journal Article
Closed access
LLLorenzo Livi
Lorenzo Livi
IMIcro Meattini
Icro Meattini
LMLivia Marrazzo
Livia Marrazzo
GSGabriele Simontacchi
Gabriele Simontacchi
SPstefania pallotta
stefania pallotta
SBSimonetta Bianchi
Simonetta Bianchi

1 June 2010 in International Journal of Radiation Oncology, Biology, Physics
Verified
Journal Article
Closed access
LLLorenzo Livi
Lorenzo Livi
FBFabrizio Banci Buonamici
Fabrizio Banci Buonamici
GSGabriele Simontacchi
Gabriele Simontacchi
VSVieri Scotti
Vieri Scotti
MFMassimiliano Fambrini
Massimiliano Fambrini
GBGiampaolo Biti
Giampaolo Biti

1 August 2018 in Radiotherapy and Oncology
Verified
Journal Article
Open access
BHBen Heijmen
Ben Heijmen
PVPeter Voet
Peter Voet
DFDennie Fransen
Dennie Fransen
JPJoan Penninkhof
Joan Penninkhof
MMMaaike Milder
Maaike Milder
SBSebastiaan Breedveld
Sebastiaan Breedveld
Reported plan quality improvements with autoplanning of radiotherapy of the prostate and seminal vesicles are poor. A system for automated multi-criterial planning has been validated for this treatment in a large international multi-center study. The system is configured with training plans using a mechanism that strives for quality improvements relative to those plans. Each of the four participating centers included thirty manually generated clinical Volumetric Modulated Arc Therapy prostate plans (manVMAT). Ten plans were used for autoplanning training. The other twenty were compared with an automatically generated plan (autoVMAT). Plan evaluations considered dosimetric plan parameters and blinded side-by-side plan comparisons by clinicians. With equivalent Planning Target Volume (PTV) V95%, D2%, D98%, and dose homogeneity autoVMAT was overall superior for rectum with median differences of 3.4 Gy (p < 0.001) in Dmean, 4.0% (p < 0.001) in V60Gy, and 1.5% (p = 0.001) in V75Gy, and for bladder Dmean (0.9 Gy, p < 0.001). Also the clinicians' plan comparisons pointed at an overall preference for autoVMAT. Advantages of autoVMAT were highly treatment center- and patient-specific with overall ranges for differences in rectum Dmean and V60Gy of [-4,12] Gy and [-2,15]%, respectively. Observed advantages of autoplanning were clinically relevant and larger than reported in the literature. The latter is likely related to the multi-criterial nature of the applied autoplanning algorithm, with for each center a dedicated configuration that aims at plan improvements relative to its (clinical) training plans. Large variations among patients in differences between manVMAT and autoVMAT point at inconsistencies in manual planning.

1 October 2017 in Dentomaxillofacial Radiology
Verified
Journal Article
Closed access
Cosimo NardiCosimo Nardi
Cosimo Nardi
CTCinzia Talamonti
Cinzia Talamonti
SPstefania pallotta
stefania pallotta
PSPaola Saletti
Paola Saletti
LCLinda Calistri
Linda Calistri
SCStefano Colagrande
Stefano Colagrande
Objectives:To evaluate the effective dose and image quality of horizontal CBCT in comparison with multislice spiral CT (MSCT) in scans of the head, cervical spine, ear and dental arches.Methods:A head and neck Alderson-Rando® phantom (The Phantom Laboratory, Salem, NY) equipped with 74 thermoluminescence dosemeters was exposed according to 5 different scans in CBCT and 4 different scans in MSCT. Spatial and contrast resolutions, in terms of modulation transfer function and contrast-to-noise ratio (CNR), were measured to obtain a quantitative assessment of image quality.Results:The CBCT effective dose was 248, 249, 361, 565 and 688 µSv in the cervical spine, head, ear, dental arches with small field of view and dental arches with medium field of view, respectively. The MSCT effective dose was 3409, 1892, 660 and 812 µSv in the cervical spine, head, ear and dental arches, respectively. The modulation transfer function was 0.895 vs 0.347, 0.895 vs 0.275, 0.875 vs 0.342 and 0.961 vs 0.352 for CBCT vs MSCT in ...

1 June 2018 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
SSSilvia Scoccianti
Silvia Scoccianti
GFGiulio Francolini
Giulio Francolini
GCGiulio Alberto Carta
Giulio Alberto Carta
DGDaniela Greto
Daniela Greto
BDBeatrice Detti
Beatrice Detti
LLLorenzo Livi
Lorenzo Livi

1 December 2015 in Physica Medica
Verified
Journal Article
Closed access
LMLivia Marrazzo
Livia Marrazzo
MZMargherita Zani
Margherita Zani
SPstefania pallotta
stefania pallotta
CAChiara Arilli
Chiara Arilli
MCMarta Casati
Marta Casati
MBMarta Bucciolini
Marta Bucciolini